Skip to main content
. 2019 Nov 7;147(3):633–640. doi: 10.1002/ijc.32750

Table 3.

Overview of cancer sites according to correctly classified and misclassified cancers

Misclassified cancers (n = 411)1
Cancer site Correctly classified cancers (n = 1,965) Date of diagnosis (n = 344) ICD code (n = 72)
More than 1 month (n = 324)2 More than 1 year (n = 20)
Head and neck 52 (73.2) 19 (26.8) 0 0
Oesophagus and gastric 124 (87.9) 13 (9.2) 0 4 (2.8)
Colorectal 361 (91.9) 25 (6.4) 1 (0.3) 6 (1.5)
Hepato‐Pancreato‐Biliary 88 (72.1) 24 (19.7) 1 (0.8) 9 (7.4)
Lung and mesothelioma 291 (82.2) 41 (11.6) 2 (0.6) 20 (5.6)
Bone and soft tissue 10 (66.7) 5 (33.3) 0 0
Breast 323 (88.3) 37 (10.1) 2 (0.5) 4 (1.1)
Female genital organs 89 (88.1) 9 (8.9) 1 (1.0) 2 (2.0)
Male genital organs 296 (77.9) 79 (20.9) 5 (1.3) 0
Unitary tract 136 (76.8) 38 (21.5) 0 3 (1.7)
Central nervous system 15 (78.9) 3 (15.8) 0 1 (5.3)
Haematological 130 (78.8) 27 (16.4) 8 (4.8) 0
Other 10 (47.6) 1 (4.8) 0 10 (47.6)
Unknown primary origin 40 (71.4) 3 (5.4) 0 13 (23.2)

Numbers are displayed in total number per cancer site (percentage per row). Cancers misclassified with regard to ICD code are classified according to the different cancer groups based on the ICD code of the Rotterdam Study.

1

Five cancers were both misclassified with regard to date >1 month and <1 year and with regard to ICD code. Therefore, the number of misclassified cancers is lower than the total number of cancers in the different misclassification categories.

2

Difference in date of diagnosis more than 1 month and less than 1 year.

Abbreviation: ICD, International Classification of Diseases.